Healthcare IT Leaders

healthcareitleaders.com

Healthcare IT Leaders is a KLAS-rated, national leader in IT workforce solutions, connecting healthcare provider and payer organizations with experienced technology talent for implementation services, consulting and full-time hiring. Areas of focus include EMR, ERP, HCM, CRM, and BI, and our consultants implement and optimize enterprise software solutions from leading vendors including Epic, Cerner, Salesforce, SAP, Oracle, ServiceNow, Infor-Lawson, and Nuvolo.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

CAMBREX COMPLETES FIRST PHASE OF $30 MILLION CAPACITY EXPANSION PROJECT IN HIGH POINT, NORTH CAROLINA

Cambrex | September 05, 2022

news image

Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient manufacturing facility in High Point, North Carolina. The newly constructed space adds analytical and chemical development laboratories totaling 30,000 square feet and provides future workspace for 85 analytical and chemical development scientists. These laboratories will support the development of APIs to be manufactured in the facility's curre...

Read More

APHRIA, ODI PHARMA EXECUTE SUPPLY AGREEMENT

ODI Pharma | November 03, 2020

news image

ODI Pharma AB today announced that, despite COVID 19 delays, it has streamlined its supply chain and executed a Supply Agreement (the "Supply Agreement") with Aphria Inc.'s ("Aphria") (TSX: APHA) (Nasdaq: APHA) wholly-owned German subsidiary, CC Pharma GmbH ("CC Pharma"). The management team of ODI believes the Supply Agreement will contribute to efficiencies of ODI's operations going forward. The highlights of the Supply Agreement are: ...

Read More

AMAG PHARMACEUTICALS ANNOUNCES CHANGES TO MEDICAL DEVELOPMENT ORGANIZATION

Send Press Releases with GlobeNewswire | March 04, 2020

news image

AMAG Pharmaceuticals, Inc. today announced changes to its medical development organization. Effective March 31, 2020, Julie Krop, M.D., Executive Vice President and Chief Medical Officer, will be leaving the Company. As AMAG initiates a search for a permanent Chief Medical Officer, the Board of Directors and management will continue to work closely with the medical development organization on key priorities, including working with the U.S. Food and Drug Administration (FDA) to find a path to ret...

Read More

Pharmacy Market

TC BIOPHARM BEGINS DOSING PHASE 2B CLINICAL STUDY EVALUATING ITS LEAD COMPOUND, OMNIMMUNE®, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

TC BioPharm | November 23, 2022

news image

TC Biopharm a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer today announced the dosing of its first three patients within its Phase 2b clinical trial of OmnImmune®, an allogeneic unmodified cell therapy focused on treating Acute Myeloid Leukemia. The initial 5 patients in the trial are deemed a "safety cohort", spaced two weeks apart with safety review by an oversight board to confirm no drug related toxic...

Read More
news image

Pharma Tech

CAMBREX COMPLETES FIRST PHASE OF $30 MILLION CAPACITY EXPANSION PROJECT IN HIGH POINT, NORTH CAROLINA

Cambrex | September 05, 2022

Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient manufacturing facility in High Point, North Carolina. The newly constructed space adds analytical and chemical development laboratories totaling 30,000 square feet and provides future workspace for 85 analytical and chemical development scientists. These laboratories will support the development of APIs to be manufactured in the facility's curre...

Read More
news image

APHRIA, ODI PHARMA EXECUTE SUPPLY AGREEMENT

ODI Pharma | November 03, 2020

ODI Pharma AB today announced that, despite COVID 19 delays, it has streamlined its supply chain and executed a Supply Agreement (the "Supply Agreement") with Aphria Inc.'s ("Aphria") (TSX: APHA) (Nasdaq: APHA) wholly-owned German subsidiary, CC Pharma GmbH ("CC Pharma"). The management team of ODI believes the Supply Agreement will contribute to efficiencies of ODI's operations going forward. The highlights of the Supply Agreement are: ...

Read More
news image

AMAG PHARMACEUTICALS ANNOUNCES CHANGES TO MEDICAL DEVELOPMENT ORGANIZATION

Send Press Releases with GlobeNewswire | March 04, 2020

AMAG Pharmaceuticals, Inc. today announced changes to its medical development organization. Effective March 31, 2020, Julie Krop, M.D., Executive Vice President and Chief Medical Officer, will be leaving the Company. As AMAG initiates a search for a permanent Chief Medical Officer, the Board of Directors and management will continue to work closely with the medical development organization on key priorities, including working with the U.S. Food and Drug Administration (FDA) to find a path to ret...

Read More
news image

Pharmacy Market

TC BIOPHARM BEGINS DOSING PHASE 2B CLINICAL STUDY EVALUATING ITS LEAD COMPOUND, OMNIMMUNE®, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

TC BioPharm | November 23, 2022

TC Biopharm a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer today announced the dosing of its first three patients within its Phase 2b clinical trial of OmnImmune®, an allogeneic unmodified cell therapy focused on treating Acute Myeloid Leukemia. The initial 5 patients in the trial are deemed a "safety cohort", spaced two weeks apart with safety review by an oversight board to confirm no drug related toxic...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us